Show simple item record

dc.contributor.authorBagby, Taryn Rochelle
dc.contributor.authorCai, Shuang
dc.contributor.authorDuan, Shaofeng
dc.contributor.authorYang, Qiuhong
dc.contributor.authorThati, Sharadvi
dc.contributor.authorBerkland, Cory J.
dc.contributor.authorAires, Daniel J.
dc.contributor.authorForrest, M. Laird
dc.date.accessioned2017-03-08T20:33:46Z
dc.date.available2017-03-08T20:33:46Z
dc.date.issued2015-01-21
dc.identifier.citationBagby, Taryn R., Shaofeng Duan, Shuang Cai, Qiuhong Yang, Sharadvi Thati, Cory Berkland, Daniel J. Aires, and M. Laird Forrest. "Lymphatic Trafficking Kinetics and Near-infrared Imaging Using Star Polymer Architectures with Controlled Anionic Character." European Journal of Pharmaceutical Sciences 47.1 (2012): 287-94.en_US
dc.identifier.urihttp://hdl.handle.net/1808/23372
dc.description.abstractTargeted lymphatic delivery of nanoparticles for drug delivery and imaging is primarily dependent on size and charge. Prior studies have observed increased lymphatic uptake and retentions of over 48 hrs for negatively charged particles compared to neutral and positively charged particles. We have developed new polymeric materials that extend retention over a more pharmaceutically relevant 7-day period. We used whole body fluorescence imaging to observe in mice the lymphatic trafficking of a series of anionic star poly-(6-O-methacryloyl-D-galactose) polymer-NIR dye (IR820) conjugates. The anionic charge of polymers was increased by modifying galactose moieties in the star polymers with succinic anhydride. Increasing anionic nature was associated with enhanced lymphatic uptake up to a zeta potential of ca. -40 mV; further negative charge did not affect lymphatic uptake. Compared to the 20% acid-conjugate, the 40 to 90% acid-star-polymer conjugates exhibited a 2.5- to 3.5-fold increase in lymphatic uptake in both the popliteal and iliac nodes. The polymer conjugates exhibited node half-lives of 2 to 20 hrs in the popliteal nodes and 19 to 114 hrs in the deeper iliac nodes. These polymer conjugates can deliver drugs or imaging agents with rapid lymphatic uptake and prolonged deep-nodal retention; thus they may provide a useful vehicle for sustained intralymphatic drug delivery with low toxicity.en_US
dc.publisherElsevieren_US
dc.rightsThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.en_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/
dc.subjectLymphaticsen_US
dc.subjectImagingen_US
dc.subjectPolymer traffickingen_US
dc.titleLymphatic trafficking kinetics and near-infrared imaging using star polymer architectures with controlled anionic characteren_US
dc.typeArticleen_US
kusw.kuauthorBerkland, Cory
kusw.kudepartmentPharmaceutical Chemistryen_US
dc.identifier.doi10.1016/j.ejps.2012.04.016en_US
dc.identifier.orcidhttps://orcid.org/0000-0001-7658-1647
kusw.oaversionScholarly/refereed, author accepted manuscripten_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Except where otherwise noted, this item's license is described as: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.